{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:35Z","timestamp":1793381075656,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T00:00:00Z","timestamp":1448064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T00:00:00Z","timestamp":1448064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000072","name":"NIDCR, NIH","doi-asserted-by":"publisher","award":["DE12889"],"award-info":[{"award-number":["DE12889"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Clark and Mildred Cox Inherited Metabolic Bone Disease Fund"},{"name":"The Hypophosphatasia Research Fund"},{"name":"The Barnes-Jewish Hospital Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00223-015-0079-1","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T06:23:31Z","timestamp":1448087011000},"page":"398-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":362,"title":["Alkaline Phosphatase and Hypophosphatasia"],"prefix":"10.1007","volume":"98","author":[{"given":"Jos\u00e9 Luis","family":"Mill\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,21]]},"reference":[{"key":"79_CR1","doi-asserted-by":"crossref","unstructured":"Robison R (1923) The possible significance of hexosephosphoric esters in ossification. Biochem J 17:286","DOI":"10.1042\/bj0170286"},{"key":"79_CR2","unstructured":"Robison R (1932) The significance of phosphoric esters in metabolism. New York University Press, New York"},{"key":"79_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-9861(84)90356-4","volume":"231","author":"JL Meyer","year":"1984","unstructured":"Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231:1\u20138","journal-title":"Arch Biochem Biophys"},{"key":"79_CR4","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","volume":"85","author":"MJ Weiss","year":"1988","unstructured":"Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA, Harris H (1988) A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci USA 85:7666\u20137669","journal-title":"Proc Natl Acad Sci USA"},{"key":"79_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","volume":"75","author":"JC Rathbun","year":"1948","unstructured":"Rathbun JC (1948) Hypophosphatasia; a new developmental anomaly. Am J Dis Child 75:822\u2013831","journal-title":"Am J Dis Child"},{"key":"79_CR6","doi-asserted-by":"crossref","unstructured":"Whyte MP (2013) Hypophosphatasia. In: Thakker RV, Whyte MP, Eisman J, Igarashi T (eds) Genetics of bone biology and skeletal disease. Academic Press, pp 337\u2013360","DOI":"10.1016\/B978-0-12-387829-8.00022-6"},{"key":"79_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75:439\u2013445","journal-title":"Ann Hum Genet"},{"key":"79_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/geno.1993.1305","volume":"17","author":"CR Greenberg","year":"1993","unstructured":"Greenberg CR, Taylor CL, Haworth JC, Seargeant LE, Philipps S, Triggs-Raine B, Chodirker BN (1993) A homoallelic Gly317\u2192Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics 17:215\u2013217","journal-title":"Genomics"},{"key":"79_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R, Thacher TD, Mayhew JE, Downs M, Mill\u00e1n JL, Skrinar AM, Crine P, Landy H (2012) Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med 366:904\u2013913","journal-title":"N Engl J Med"},{"key":"79_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/3527608060","volume-title":"Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology","author":"JL Mill\u00e1n","year":"2006","unstructured":"Mill\u00e1n JL (2006) Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Wiley-VCH Verlag GmbH & Co., Weinheim"},{"key":"79_CR11","doi-asserted-by":"publisher","first-page":"9158","DOI":"10.1074\/jbc.M009250200","volume":"276","author":"MH Le Du","year":"2001","unstructured":"Le Du MH, Stigbrand T, Taussig MJ, Menez A, Stura EA (2001) Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity. J Biol Chem 276:9158\u20139165","journal-title":"J Biol Chem"},{"key":"79_CR12","doi-asserted-by":"publisher","first-page":"49808","DOI":"10.1074\/jbc.M207394200","volume":"277","author":"M-H Le Du","year":"2002","unstructured":"Le Du M-H, Mill\u00e1n JL (2002) Structural evidence of functional divergence in human alkaline phosphatases. J Biol Chem 277:49808\u201349814","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"79_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1042\/bj2740091","volume":"274","author":"C Hummer","year":"1991","unstructured":"Hummer C, Mill\u00e1n JL (1991) Gly429 is the major determinant of uncompetitive inhibition of human germ cell alkaline phosphatase by L-leucine. Biochem J 274(Pt 1):91\u201395","journal-title":"Biochem J"},{"issue":"Pt 1","key":"79_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/bj2860023","volume":"286","author":"MF Hoylaerts","year":"1992","unstructured":"Hoylaerts MF, Manes T, Mill\u00e1n JL (1992) Molecular mechanism of uncompetitive inhibition of human placental and germ-cell alkaline phosphatase. Biochem J 286(Pt 1):23\u201330","journal-title":"Biochem J"},{"key":"79_CR15","doi-asserted-by":"publisher","first-page":"22992","DOI":"10.1074\/jbc.M202298200","volume":"277","author":"A Kozlenkov","year":"2002","unstructured":"Kozlenkov A, Manes T, Hoylaerts MF, Millan JL (2002) Function assignment to conserved residues in mammalian alkaline phosphatases. J Biol Chem 277:22992\u201322999","journal-title":"J Biol Chem"},{"key":"79_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1042\/bj2540623","volume":"254","author":"PA Tsonis","year":"1988","unstructured":"Tsonis PA, Argraves WS, Mill\u00e1n JL (1988) A putative functional domain of human placental alkaline phosphatase predicted from sequence comparisons. Biochem J 254:623\u2013624","journal-title":"Biochem J"},{"key":"79_CR17","doi-asserted-by":"publisher","first-page":"9756","DOI":"10.1021\/bi052471+","volume":"45","author":"MF Hoylaerts","year":"2006","unstructured":"Hoylaerts MF, Ding L, Narisawa S, Van Kerckhoven S, Mill\u00e1n JL (2006) Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. Biochemistry 45:9756\u20139766","journal-title":"Biochemistry"},{"key":"79_CR18","doi-asserted-by":"publisher","first-page":"22781","DOI":"10.1074\/jbc.272.36.22781","volume":"272","author":"MF Hoylaerts","year":"1997","unstructured":"Hoylaerts MF, Manes T, Mill\u00e1n JL (1997) Mammalian alkaline phosphatases are allosteric enzymes. J Biol Chem 272:22781\u201322787","journal-title":"J Biol Chem"},{"key":"79_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2350-10-51","volume":"10","author":"D Fauvert","year":"2009","unstructured":"Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E (2009) Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 10:51","journal-title":"BMC Med Genet"},{"key":"79_CR20","doi-asserted-by":"publisher","first-page":"31171","DOI":"10.1074\/jbc.M102788200","volume":"276","author":"E Mornet","year":"2001","unstructured":"Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH (2001) Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 276:31171\u201331178","journal-title":"J Biol Chem"},{"key":"79_CR21","doi-asserted-by":"publisher","first-page":"e0119874","DOI":"10.1371\/journal.pone.0119874","volume":"10","author":"MF Hoylaerts","year":"2015","unstructured":"Hoylaerts MF, Van Kerckhoven S, Kiffer-Moreira T, Sheen C, Narisawa S, Millan JL (2015) Functional significance of calcium binding to tissue-nonspecific alkaline phosphatase. PLoS One 10:e0119874","journal-title":"PLoS One"},{"key":"79_CR22","doi-asserted-by":"crossref","first-page":"18513","DOI":"10.1016\/S0021-9258(19)81388-1","volume":"263","author":"BR Genge","year":"1988","unstructured":"Genge BR, Sauer GR, Wu LN, McLean FM, Wuthier RE (1988) Correlation between loss of alkaline phosphatase activity and accumulation of calcium during matrix vesicle-mediated mineralization. J Biol Chem 263:18513\u201318519","journal-title":"J Biol Chem"},{"key":"79_CR23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1139\/o02-146","volume":"80","author":"FJ Sharom","year":"2002","unstructured":"Sharom FJ, Lehto MT (2002) Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C. Biochem Cell Biol 80:535\u2013549","journal-title":"Biochem Cell Biol"},{"issue":"Pt 1","key":"79_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/bj3010205","volume":"301","author":"YW Wong","year":"1994","unstructured":"Wong YW, Low MG (1994) Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form. Biochem J 301(Pt 1):205\u2013209","journal-title":"Biochem J"},{"key":"79_CR25","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1073\/pnas.83.19.7182","volume":"83","author":"MJ Weiss","year":"1986","unstructured":"Weiss MJ, Henthorn PS, Lafferty MA, Slaughter C, Raducha M, Harris H (1986) Isolation and characterization of a cDNA encoding a human liver\/bone\/kidney-type alkaline phosphatase. Proc Natl Acad Sci USA 83:7182\u20137186","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"79_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3210297","volume":"321","author":"O Nosjean","year":"1997","unstructured":"Nosjean O, Koyama I, Goseki M, Roux B, Komoda T (1997) Human tissue non-specific alkaline phosphatases: sugar-moiety-induced enzymic and antigenic modulations and genetic aspects. Biochem J 321(Pt 2):297\u2013303","journal-title":"Biochem J"},{"key":"79_CR27","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","volume":"45","author":"C Halling Linder","year":"2009","unstructured":"Halling Linder C, Narisawa S, Mill\u00e1n JL, Magnusson P (2009) Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 45:987\u2013993","journal-title":"Bone"},{"key":"79_CR28","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1359\/jbmr.1999.14.12.2015","volume":"14","author":"KN Fedde","year":"1999","unstructured":"Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Mill\u00e1n JL, MacGregor GR, Whyte MP (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015\u20132026","journal-title":"J Bone Miner Res"},{"key":"79_CR29","first-page":"767","volume":"47","author":"KN Fedde","year":"1990","unstructured":"Fedde KN, Whyte MP (1990) Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5\u2032-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study. Am J Hum Genet 47:767\u2013775","journal-title":"Am J Hum Genet"},{"key":"79_CR30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.091023","volume":"25","author":"P Ciancaglini","year":"2010","unstructured":"Ciancaglini P, Yadav MC, Sim\u00e3o AM, Narisawa S, Pizauro JM, Farquharson C, Hoylaerts MF, Mill\u00e1n JL (2010) Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res 25:716\u2013723","journal-title":"J Bone Miner Res"},{"key":"79_CR31","doi-asserted-by":"publisher","first-page":"27315","DOI":"10.1074\/jbc.M113.484212","volume":"288","author":"M Pettengill","year":"2013","unstructured":"Pettengill M, Robson S, Tresenriter M, Millan JL, Usheva A, Bingham T, Belderbos M, Bergelson I, Burl S, Kampmann B, Gelinas L, Kollmann T, Bont L, Levy O (2013) Soluble ecto-5\u2032-nucleotidase (5\u2032-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine. J Biol Chem 288:27315\u201327326","journal-title":"J Biol Chem"},{"key":"79_CR32","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.1523\/JNEUROSCI.0133-13.2013","volume":"33","author":"SE Street","year":"2013","unstructured":"Street SE, Kramer NJ, Walsh PL, Taylor-Blake B, Yadav MC, King IF, Vihko P, Wightman RM, Millan JL, Zylka MJ (2013) Tissue-nonspecific alkaline phosphatase acts redundantly with PAP and NT5E to generate adenosine in the dorsal spinal cord. J Neurosci 33:11314\u201311322","journal-title":"J Neurosci"},{"key":"79_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/REP-13-0153","volume":"146","author":"W Lei","year":"2013","unstructured":"Lei W, Nguyen H, Brown N, Ni H, Kiffer-Moreira T, Reese J, Millan JL, Paria BC (2013) Alkaline phosphatases contribute to uterine receptivity, implantation, decidualization, and defense against bacterial endotoxin in hamsters. Reproduction 146:419\u2013432","journal-title":"Reproduction"},{"key":"79_CR34","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/jbmr.1901","volume":"28","author":"S Narisawa","year":"2013","unstructured":"Narisawa S, Yadav MC, Millan JL (2013) In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res 28:1587\u20131598","journal-title":"J Bone Miner Res"},{"key":"79_CR35","doi-asserted-by":"crossref","unstructured":"Whyte MP (2015) Hypophosphatasia: etiology, nosology, pathogenesis, diagnosis, and treatment. Nat Rev Endocrinol (in press)","DOI":"10.1038\/nrendo.2016.14"},{"key":"79_CR36","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S (2015) Hypophosphatasia: validation and expansion of the clinical nosology for children from 25\u00a0years experience with 173 pediatric patients. Bone 75:229\u2013239","journal-title":"Bone"},{"key":"79_CR37","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/jbmr.454","volume":"26","author":"D Wenkert","year":"2011","unstructured":"Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL, Hersh JH, Mumm S, Whyte MP (2011) Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 26:2389\u20132398","journal-title":"J Bone Miner Res"},{"key":"79_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","volume":"40","author":"S Baumgartner-Sigl","year":"2007","unstructured":"Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Burgi S, Sergi C, Ryan L, Ericson KL, Whyte MP, Hogler W (2007) Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p. M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 40:1655\u20131661","journal-title":"Bone"},{"key":"79_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/154405910508401110","volume":"84","author":"T van den Bos","year":"2005","unstructured":"van den Bos T, Handoko G, Niehof A, Ryan LM, Coburn SP, Whyte MP, Beertsen W (2005) Cementum and dentin in hypophosphatasia. J Dent Res 84:1021\u20131025","journal-title":"J Dent Res"},{"key":"79_CR40","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1359\/jbmr.090308","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP, Wenkert D, McAlister WH, Mughal Z, Freemont AJ, Whitehouse R, Baildam E, Mumm S (2009) Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res 24:1493\u20131505","journal-title":"J Bone Miner Res"},{"key":"79_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00005792-197909000-00001","volume":"58","author":"MP Whyte","year":"1979","unstructured":"Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV (1979) Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 58:329\u2013347","journal-title":"Medicine (Baltimore)"},{"key":"79_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0002-9343(82)90474-0","volume":"72","author":"MP Whyte","year":"1982","unstructured":"Whyte MP, Murphy WA, Fallon MD (1982) Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred. Am J Med 72:631\u2013641","journal-title":"Am J Med"},{"key":"79_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng0995-45","volume":"11","author":"KG Waymire","year":"1995","unstructured":"Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR (1995) Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 11:45\u201351","journal-title":"Nat Genet"},{"key":"79_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1","volume":"208","author":"S Narisawa","year":"1997","unstructured":"Narisawa S, Frohlander N, Millan JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432\u2013446","journal-title":"Dev Dyn"},{"key":"79_CR45","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1172\/JCI112031","volume":"76","author":"MP Whyte","year":"1985","unstructured":"Whyte MP, Mahuren JD, Vrabel LA, Coburn SP (1985) Markedly increased circulating pyridoxal-5\u2032-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 76:752\u2013756","journal-title":"J Clin Invest"},{"key":"79_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bone.2012.12.048","volume":"53","author":"C Halling Linder","year":"2013","unstructured":"Halling Linder C, Englund UH, Narisawa S, Millan JL, Magnusson P (2013) Isozyme profile and tissue-origin of alkaline phosphatases in mouse serum. Bone 53:399\u2013408","journal-title":"Bone"},{"key":"79_CR47","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1177\/00220345990780060501","volume":"78","author":"W Beertsen","year":"1999","unstructured":"Beertsen W, VandenBos T, Everts V (1999) Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formation. J Dent Res 78:1221\u20131229","journal-title":"J Dent Res"},{"key":"79_CR48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/0022034510393517","volume":"90","author":"MD McKee","year":"2011","unstructured":"McKee MD, Nakano Y, Masica DL, Gray JJ, Lemire I, Heft R, Whyte MP, Crine P, Mill\u00e1n JL (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90:470\u2013476","journal-title":"J Dent Res"},{"key":"79_CR49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jbmr.1767","volume":"28","author":"BL Foster","year":"2013","unstructured":"Foster BL, Nagatomo KJ, Tso HW, Tran AB, Nociti FH Jr, Narisawa S, Yadav MC, McKee MD, Millan JI, Somerman MJ (2013) Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res 28:271\u2013282","journal-title":"J Bone Miner Res"},{"key":"79_CR50","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/jbmr.1619","volume":"27","author":"MC Yadav","year":"2012","unstructured":"Yadav MC, de Oliveira RC, Foster BL, Fong H, Cory E, Narisawa S, Sah RL, Somerman M, Whyte MP, Millan JL (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27:1722\u20131734","journal-title":"J Bone Miner Res"},{"key":"79_CR51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bone.2014.06.040","volume":"67","author":"J Liu","year":"2014","unstructured":"Liu J, Nam HK, Campbell C, Gasque KC, Millan JL, Hatch NE (2014) Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(\u2212\/\u2212) mouse model of infantile hypophosphatasia. Bone 67:81\u201394","journal-title":"Bone"},{"key":"79_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH722>3.0.CO;2-Y","volume":"193","author":"S Narisawa","year":"2001","unstructured":"Narisawa S, Wennberg C, Mill\u00e1n JL (2001) Abnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralization. J. Pathol. 193:125\u2013133","journal-title":"J. Pathol."},{"key":"79_CR53","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1113\/expphysiol.2008.045864","volume":"94","author":"B Aigner","year":"2009","unstructured":"Aigner B, Rathkolb B, Klaften M, Sedlmeier R, Klempt M, Wagner S, Michel D, Mayer U, Klopstock T, de Angelis MH, Wolf E (2009) Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models. Exp Physiol 94:412\u2013421","journal-title":"Exp Physiol"},{"key":"79_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s00335-012-9397-z","volume":"23","author":"S Sabrautzki","year":"2012","unstructured":"Sabrautzki S, Rubio-Aliaga I, Hans W, Fuchs H, Rathkolb B, Calzada-Wack J, Cohrs CM, Klaften M, Seedorf H, Eck S, Benet-Pages A, Favor J, Esposito I, Strom TM, Wolf E, Lorenz-Depiereux B, Hrabe de Angelis M (2012) New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis. Mamm Genome 23:416\u2013430","journal-title":"Mamm Genome"},{"key":"79_CR55","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1359\/jbmr.070515","volume":"22","author":"TA Hough","year":"2007","unstructured":"Hough TA, Polewski M, Johnson K, Cheeseman M, Nolan PM, Vizor L, Rastan S, Boyde A, Pritzker K, Hunter AJ, Fisher EMC, Terkeltaub R, Brown SDM (2007) Novel mouse model of autosomal semidominant adult hypophosphatasia has a splice site mutation in the tissue nonspecific alkaline phosphatase gene Akp2. J Bone Miner Res 22:1397\u20131407","journal-title":"J Bone Miner Res"},{"key":"79_CR56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1177\/0022034515573273","volume":"94","author":"BL Foster","year":"2015","unstructured":"Foster BL, Sheen CR, Hatch NE, Liu J, Cory E, Narisawa S, Kiffer-Moreira T, Sah RL, Whyte MP, Somerman MJ, Millan JL (2015) Periodontal defects in the A116T knock-in murine model of odontohypophosphatasia. J Dent Res 94:706\u2013714","journal-title":"J Dent Res"},{"key":"79_CR57","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1073\/pnas.67.3.1513","volume":"67","author":"SY Ali","year":"1970","unstructured":"Ali SY, Sajdera SW, Anderson HC (1970) Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc Natl Acad Sci USA 67:1513\u20131520","journal-title":"Proc Natl Acad Sci USA"},{"key":"79_CR58","first-page":"218","volume":"135","author":"GW Bernard","year":"1978","unstructured":"Bernard GW (1978) Ultrastructural localization of alkaline phosphatase in initial intramembranous osteogenesis. Clin Orthop Relat Res 135:218\u2013225","journal-title":"Clin Orthop Relat Res"},{"key":"79_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0169-6009(92)90877-G","volume":"19","author":"DC Morris","year":"1992","unstructured":"Morris DC, Masuhara K, Takaoka K, Ono K, Anderson HC (1992) Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. Bone Miner 19:287\u2013298","journal-title":"Bone Miner"},{"key":"79_CR60","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0002-9440(10)62481-9","volume":"166","author":"HC Anderson","year":"2005","unstructured":"Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, Bi X, Johnson K, Terkeltaub R, Millan JL (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase\/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166:1711\u20131720","journal-title":"Am J Pathol"},{"key":"79_CR61","first-page":"1555","volume":"151","author":"HC Anderson","year":"1997","unstructured":"Anderson HC, Hsu HH, Morris DC, Fedde KN, Whyte MP (1997) Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 151:1555\u20131561","journal-title":"Am J Pathol"},{"key":"79_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0002-9440(10)63172-0","volume":"164","author":"HC Anderson","year":"2004","unstructured":"Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millan JL (2004) Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164:841\u2013847","journal-title":"Am J Pathol"},{"key":"79_CR63","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","volume":"2","author":"RG Russell","year":"1965","unstructured":"Russell RG (1965) Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet 2:461\u2013464","journal-title":"Lancet"},{"key":"79_CR64","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1172\/JCI106589","volume":"50","author":"RG Russell","year":"1971","unstructured":"Russell RG, Bisaz S, Donath A, Morgan DB, Fleisch H (1971) Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. J Clin Invest 50:961\u2013969","journal-title":"J Clin Invest"},{"key":"79_CR65","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/212901a0","volume":"212","author":"H Fleisch","year":"1966","unstructured":"Fleisch H, Russell RG, Straumann F (1966) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212:901\u2013903","journal-title":"Nature"},{"key":"79_CR66","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0002-9440(10)63208-7","volume":"164","author":"D Harmey","year":"2004","unstructured":"Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Mill\u00e1n JL (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199\u20131209","journal-title":"Am J Pathol"},{"key":"79_CR67","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1073\/pnas.142063399","volume":"99","author":"L Hessle","year":"2002","unstructured":"Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445\u20139449","journal-title":"Proc Natl Acad Sci USA"},{"key":"79_CR68","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","volume":"279","author":"KA Johnson","year":"2000","unstructured":"Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 279:R1365\u2013R1377","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"79_CR69","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1074\/jbc.M109.079830","volume":"285","author":"AM Simao","year":"2010","unstructured":"Simao AM, Yadav MC, Narisawa S, Bolean M, Pizauro JM, Hoylaerts MF, Ciancaglini P, Millan JL (2010) Proteoliposomes harboring alkaline phosphatase and nucleotide pyrophosphatase as matrix vesicle biomimetics. J Biol Chem 285:7598\u20137609","journal-title":"J Biol Chem"},{"key":"79_CR70","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jbmr.195","volume":"26","author":"MC Yadav","year":"2011","unstructured":"Yadav MC, Sim\u00e3o AM, Narisawa S, Huesa C, McKee MD, Farquharson C, Mill\u00e1n JL (2011) Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res 26:286\u2013297","journal-title":"J Bone Miner Res"},{"key":"79_CR71","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00223-012-9672-8","volume":"93","author":"JL Millan","year":"2013","unstructured":"Millan JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93:299\u2013306","journal-title":"Calcif Tissue Int"},{"key":"79_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1042\/bj1020053","volume":"102","author":"DW Moss","year":"1967","unstructured":"Moss DW, Eaton RH, Smith JK, Whitby LG (1967) Association of inorganic-pyrophosphatase activity with human alkaline-phosphatase preparations. Biochem J 102:53\u201357","journal-title":"Biochem J"},{"key":"79_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0005-2744(75)90151-5","volume":"391","author":"RJ Majeska","year":"1975","unstructured":"Majeska RJ, Wuthier RE (1975) Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys Acta 391:51\u201360","journal-title":"Biochim Biophys Acta"},{"key":"79_CR74","first-page":"489","volume":"43","author":"MD Fallon","year":"1980","unstructured":"Fallon MD, Whyte MP, Teitelbaum SL (1980) Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification. Lab Invest 43:489\u2013494","journal-title":"Lab Invest"},{"issue":"Pt 2","key":"79_CR75","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1042\/bj3010517","volume":"301","author":"AA Rezende","year":"1994","unstructured":"Rezende AA, Pizauro JM, Ciancaglini P, Leone FA (1994) Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate. Biochem J 301(Pt 2):517\u2013522","journal-title":"Biochem J"},{"key":"79_CR76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1523-1747.2003.12034.x","volume":"120","author":"SP Coburn","year":"2003","unstructured":"Coburn SP, Slominski A, Mahuren JD, Wortsman J, Hessle L, Mill\u00e1n JL (2003) Cutaneous metabolism of vitamin B-6. J Invest Dermatol 120:292\u2013300","journal-title":"J Invest Dermatol"},{"key":"79_CR77","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0959-440X(98)80096-1","volume":"8","author":"JN Jansonius","year":"1998","unstructured":"Jansonius JN (1998) Structure, evolution and action of vitamin B6-dependent enzymes. Curr Opin Struct Biol 8:759\u2013769","journal-title":"Curr Opin Struct Biol"},{"key":"79_CR78","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1172\/JCI117814","volume":"95","author":"MP Whyte","year":"1995","unstructured":"Whyte MP, Landt M, Ryan LM, Mulivor RA, Henthorn PS, Fedde KN, Mahuren JD, Coburn SP (1995) Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5\u2032-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest 95:1440\u20131445","journal-title":"J Clin Invest"},{"key":"79_CR79","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/BF01800216","volume":"13","author":"BN Chodirker","year":"1990","unstructured":"Chodirker BN, Coburn SP, Seargeant LE, Whyte MP, Greenberg CR (1990) Increased plasma pyridoxal-5\u2032-phosphate levels before and after pyridoxine loading in carriers of perinatal\/infantile hypophosphatasia. J Inherit Metab Dis 13:891\u2013896","journal-title":"J Inherit Metab Dis"},{"key":"79_CR80","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1172\/JCI113440","volume":"81","author":"MP Whyte","year":"1988","unstructured":"Whyte MP, Mahuren JD, Fedde KN, Cole FS, McCabe ER, Coburn SP (1988) Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5\u2032-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest 81:1234\u20131239","journal-title":"J Clin Invest"},{"key":"79_CR81","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/aja.1002010306","volume":"201","author":"S Narisawa","year":"1994","unstructured":"Narisawa S, Hasegawa H, Watanabe K, Mill\u00e1n JL (1994) Stage-specific expression of alkaline phosphatase during neural development in the mouse. Dev Dyn 201:227\u2013235","journal-title":"Dev Dyn"},{"key":"79_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-7197-9","volume-title":"Neuronal tissue-nonspecific alkaline phosphatase (TNAP)","author":"C Fonta","year":"2015","unstructured":"Fonta C, Negyessy L (2015) Subcellular biochemistry. In: Fonta C, Negyessy L (eds) Neuronal tissue-nonspecific alkaline phosphatase (TNAP). Springer, Dordrecht"},{"key":"79_CR83","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00441-012-1455-z","volume":"349","author":"J Hanics","year":"2012","unstructured":"Hanics J, Barna J, Xiao J, Millan JL, Fonta C, Negyessy L (2012) Ablation of TNAP function compromises myelination and synaptogenesis in the mouse brain. Cell Tissue Res 349:459\u2013471","journal-title":"Cell Tissue Res"},{"key":"79_CR84","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0006-291X(69)90656-1","volume":"36","author":"HL Fleshood","year":"1969","unstructured":"Fleshood HL, Pitot HC (1969) O-phosphorylethanolamine ammonia lyase, a new pyridoxal phosphate-dependent enzyme. Biochem Biophys Res Commun 36:110\u2013118","journal-title":"Biochem Biophys Res Commun"},{"key":"79_CR85","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/S0021-9258(19)63811-1","volume":"245","author":"HL Fleshood","year":"1970","unstructured":"Fleshood HL, Pitot HC (1970) The metabolism of O-phosphorylethanolamine in animal tissues. I. O-phosphorylethanolamine phospho-lyase: partial purification and characterization. J Biol Chem 245:4414\u20134420","journal-title":"J Biol Chem"},{"key":"79_CR86","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0003-9861(70)90158-X","volume":"141","author":"HL Fleshood","year":"1970","unstructured":"Fleshood HL, Pitot HC (1970) The metabolism of O-phosphorylethanolamine in animal tissues. II. Metabolic regulation of O-phosphorylethanolamine phospho-lyase in vivo. Arch Biochem Biophys 141:423\u2013429","journal-title":"Arch Biochem Biophys"},{"key":"79_CR87","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clinchem\/26.7.840","volume":"26","author":"JL Mill\u00e1n","year":"1980","unstructured":"Mill\u00e1n JL, Whyte MP, Avioli LV, Fishman WH (1980) Hypophosphatasia (adult form): quantitation of serum alkaline phosphatase isoenzyme activity in a large kindred. Clin Chem 26:840\u2013845","journal-title":"Clin Chem"},{"key":"79_CR88","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1359\/jbmr.2000.15.10.1879","volume":"15","author":"C Wennberg","year":"2000","unstructured":"Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Mill\u00e1n JL (2000) Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 15:1879\u20131888","journal-title":"J Bone Miner Res"},{"key":"79_CR89","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1359\/jbmr.2003.18.6.994","volume":"18","author":"K Johnson","year":"2003","unstructured":"Johnson K, Goding J, Van Etten D, Sali A, Hu SI, Farley D, Krug H, Hessle L, Mill\u00e1n JL, Terkeltaub R (2003) Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res 18:994\u20131004","journal-title":"J Bone Miner Res"},{"key":"79_CR90","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1359\/jbmr.060619","volume":"21","author":"D Harmey","year":"2006","unstructured":"Harmey D, Johnson KA, Zelken J, Camacho NP, Hoylaerts MF, Noda M, Terkeltaub R, Mill\u00e1n JL (2006) Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(\u2212\/\u2212) mice. J Bone Miner Res 21:1377\u20131386","journal-title":"J Bone Miner Res"},{"key":"79_CR91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/03008200109014246","volume":"42","author":"HA Goldberg","year":"2001","unstructured":"Goldberg HA, Warner KJ, Li MC, Hunter GK (2001) Binding of bone sialoprotein, osteopontin and synthetic polypeptides to hydroxyapatite. Connect Tissue Res 42:25\u201337","journal-title":"Connect Tissue Res"},{"key":"79_CR92","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/BJ20050341","volume":"390","author":"B Christensen","year":"2005","unstructured":"Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sorensen ES (2005) Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J 390:285\u2013292","journal-title":"Biochem J"},{"issue":"Pt 3","key":"79_CR93","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1042\/bj3000723","volume":"300","author":"GK Hunter","year":"1994","unstructured":"Hunter GK, Kyle CL, Goldberg HA (1994) Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 300(Pt 3):723\u2013728","journal-title":"Biochem J"},{"key":"79_CR94","doi-asserted-by":"publisher","first-page":"20197","DOI":"10.1074\/jbc.M909174199","volume":"275","author":"S Jono","year":"2000","unstructured":"Jono S, Peinado C, Giachelli CM (2000) Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275:20197\u201320203","journal-title":"J Biol Chem"},{"key":"79_CR95","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1042\/bj20031150","volume":"378","author":"DA Pampena","year":"2004","unstructured":"Pampena DA, Robertson KA, Litvinova O, Lajoie G, Goldberg HA, Hunter GK (2004) Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J 378:1083\u20131087","journal-title":"Biochem J"},{"key":"79_CR96","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jbmr.110","volume":"25","author":"WN Addison","year":"2010","unstructured":"Addison WN, Masica DL, Gray JJ, McKee MD (2010) Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage. J Bone Miner Res 25:695\u2013705","journal-title":"J Bone Miner Res"},{"key":"79_CR97","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/jbmr.2281","volume":"29","author":"MC Yadav","year":"2014","unstructured":"Yadav MC, Huesa C, Narisawa S, Hoylaerts MF, Moreau A, Farquharson C, Millan JL (2014) Ablation of osteopontin improves the skeletal phenotype of phospho1(\u2212\/\u2212) mice. J Bone Miner Res 29:2369\u20132381","journal-title":"J Bone Miner Res"},{"key":"79_CR98","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1073\/pnas.0712140105","volume":"105","author":"RF Goldberg","year":"2008","unstructured":"Goldberg RF, Austen WG Jr, Zhang X, Munene G, Mostafa G, Biswas S, McCormack M, Eberlin KR, Nguyen JT, Tatlidede HS, Warren HS, Narisawa S, Mill\u00e1n JL, Hodin RA (2008) Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci USA 105:3551\u20133556","journal-title":"Proc Natl Acad Sci USA"},{"key":"79_CR99","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/gut.2010.211706","volume":"59","author":"MS Malo","year":"2010","unstructured":"Malo MS, Alam SN, Mostafa G, Zeller SJ, Johnson PV, Mohammad N, Chen KT, Moss AK, Ramasamy S, Faruqui A, Hodin S, Malo PS, Ebrahimi F, Biswas B, Narisawa S, Millan JL, Warren HS, Kaplan JB, Kitts CL, Hohmann EL, Hodin RA (2010) Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59:1476\u20131484","journal-title":"Gut"},{"key":"79_CR100","doi-asserted-by":"publisher","first-page":"G826","DOI":"10.1152\/ajpgi.00357.2013","volume":"306","author":"MS Malo","year":"2014","unstructured":"Malo MS, Moaven O, Muhammad N, Biswas B, Alam SN, Economopoulos KP, Gul SS, Hamarneh SR, Malo NS, Teshager A, Mohamed MM, Tao Q, Narisawa S, Millan JL, Hohmann EL, Warren HS, Robson SC, Hodin RA (2014) Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates. Am J Physiol Gastrointest Liver Physiol 306:G826\u2013G838","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"79_CR101","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1097\/01.PRS.0000056839.94034.47","volume":"111","author":"J Panchal","year":"2003","unstructured":"Panchal J, Uttchin V (2003) Management of craniosynostosis. Plast Reconstr Surg 111:2032\u20132048 quiz 2049","journal-title":"Plast Reconstr Surg"},{"key":"79_CR102","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bone.2015.05.005","volume":"78","author":"J Liu","year":"2015","unstructured":"Liu J, Campbell C, Nam HK, Caron A, Yadav MC, Millan JL, Hatch NE (2015) Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia. Bone 78:203\u2013211","journal-title":"Bone"},{"key":"79_CR103","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2014.11.017","volume":"72","author":"KC Gasque","year":"2015","unstructured":"Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, van Elsas A, Hatch N, Somerman MJ, Millan JL (2015) Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl(\u2212\/\u2212) mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Bone 72:137\u2013147","journal-title":"Bone"},{"key":"79_CR104","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/jpm.2010.028","volume":"38","author":"B Weber","year":"2010","unstructured":"Weber B, Schwabegger AH, Oberaigner W, Rumer-Moser A, Steiner H (2010) Incidence of perinatal complications in children with premature craniosynostosis. J Perinat Med 38:319\u2013325","journal-title":"J Perinat Med"},{"key":"79_CR105","first-page":"141","volume":"53","author":"JM Baumann","year":"1977","unstructured":"Baumann JM, Bisaz S, Felix R, Fleisch H, Ganz U, Russell RG (1977) The role of inhibitors and other factors in the pathogenesis of recurrent calcium-containing renal stones. Clin Sci Mol Med 53:141\u2013148","journal-title":"Clin Sci Mol Med"},{"key":"79_CR106","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000186179","volume":"56","author":"NA Laminski","year":"1990","unstructured":"Laminski NA, Meyers AM, Sonnekus MI, Smyth AE (1990) Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities. Nephron 56:379\u2013386","journal-title":"Nephron"},{"key":"79_CR107","first-page":"177","volume":"48","author":"RG Russell","year":"1975","unstructured":"Russell RG, Smith R, Preston C, Walton RJ, Woods CG, Henderson RG, Norman AW (1975) The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets. Clin Sci Mol Med 48:177\u2013186","journal-title":"Clin Sci Mol Med"},{"key":"79_CR108","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/ppul.22527","volume":"47","author":"E Rodriguez","year":"2012","unstructured":"Rodriguez E, Bober MB, Davey L, Zamora A, Li Puma AB, Chidekel A, Shaffer TH (2012) Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy. Pediatr Pulmonol 47:917\u2013922","journal-title":"Pediatr Pulmonol"},{"key":"79_CR109","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2106\/00004623-198668070-00004","volume":"68","author":"JD Coe","year":"1986","unstructured":"Coe JD, Murphy WA, Whyte MP (1986) Management of femoral fractures and pseudofractures in adult hypophosphatasia. J Bone Joint Surg Am 68:981\u2013990","journal-title":"J Bone Joint Surg Am"},{"key":"79_CR110","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0022-3476(82)80061-9","volume":"101","author":"MP Whyte","year":"1982","unstructured":"Whyte MP, Valdes R Jr, Ryan LM, McAlister WH (1982) Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget\u2019s bone disease. J Pediatr 101:379\u2013386","journal-title":"J Pediatr"},{"key":"79_CR111","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0022-3476(84)80079-7","volume":"105","author":"MP Whyte","year":"1984","unstructured":"Whyte MP, McAlister WH, Patton LS, Magill HL, Fallon MD, Lorentz WB Jr, Herrod HG (1984) Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. J Pediatr 105:926\u2013933","journal-title":"J Pediatr"},{"key":"79_CR112","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1651-2227.1989.tb11297.x","volume":"360","author":"M Weninger","year":"1989","unstructured":"Weninger M, Stinson RA, Plenk H Jr, Bock P, Pollak A (1989) Biochemical and morphological effects of human hepatic alkaline phosphatase in a neonate with hypophosphatasia. Acta Paediatr Scand Suppl 360:154\u2013160","journal-title":"Acta Paediatr Scand Suppl"},{"key":"79_CR113","first-page":"S155","volume":"7","author":"MP Whyte","year":"1992","unstructured":"Whyte MP, Habib D, Coburn SP, Tecklenburg F, Ryan L, Fedde KN, Stinson RA (1992) Failure of hyperphosphatasemia by intravenous infusion of purified placental alkaline phosphatase (ALP) to correct severe hypophosphatasia: evidence against a role for circulating ALP in skeletal mineralization\u00a0(abstract). J Bone Miner Res 7:S155","journal-title":"J Bone Miner Res"},{"key":"79_CR114","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","volume":"18","author":"MP Whyte","year":"2003","unstructured":"Whyte MP, Kurtzberg J, McAlister WH, Mumm S, Podgornik MN, Coburn SP, Ryan LM, Miller CR, Gottesman GS, Smith AK, Douville J, Waters-Pick B, Armstrong RD, Martin PL (2003) Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18:624\u2013636","journal-title":"J Bone Miner Res"},{"key":"79_CR115","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1210\/jc.2006-2131","volume":"92","author":"RA Cahill","year":"2007","unstructured":"Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAlister WH, Mumm S, Whyte MP (2007) Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 92:2923\u20132930","journal-title":"J Clin Endocrinol Metab"},{"key":"79_CR116","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92:1203\u20131208","journal-title":"J Clin Endocrinol Metab"},{"key":"79_CR117","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4158\/EP.14.2.204","volume":"14","author":"PM Camacho","year":"2008","unstructured":"Camacho PM, Painter S, Kadanoff R (2008) Treatment of adult hypophosphatasia with teriparatide. Endocr Pract 14:204\u2013208","journal-title":"Endocr Pract"},{"key":"79_CR118","first-page":"266","volume":"6","author":"KB Doshi","year":"2009","unstructured":"Doshi KB, Hamrahian AH, Licata AA (2009) Teriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case report. Clin Cases Miner Bone Metab 6:266\u2013269","journal-title":"Clin Cases Miner Bone Metab"},{"key":"79_CR119","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1210\/jc.2010-1168","volume":"95","author":"C Schalin-Jantti","year":"2010","unstructured":"Schalin-Jantti C, Mornet E, Lamminen A, Valimaki MJ (2010) Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab 95:5174\u20135179","journal-title":"J Clin Endocrinol Metab"},{"key":"79_CR120","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1210\/jc.2009-1965","volume":"95","author":"C Gagnon","year":"2010","unstructured":"Gagnon C, Sims NA, Mumm S, McAuley SA, Jung C, Poulton IJ, Ng KW, Ebeling PR (2010) Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab 95:1007\u20131012","journal-title":"J Clin Endocrinol Metab"},{"key":"79_CR121","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00223-011-9562-5","volume":"90","author":"M Laroche","year":"2012","unstructured":"Laroche M (2012) Failure of teriparatide in treatment of bone complications of adult hypophosphatasia. Calcif Tissue Int 90:250","journal-title":"Calcif Tissue Int"},{"key":"79_CR122","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/01926230490462138","volume":"32","author":"JL Vahle","year":"2004","unstructured":"Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M (2004) Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose. Toxicol Pathol 32:426\u2013438","journal-title":"Toxicol Pathol"},{"key":"79_CR123","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/jbmr.2092","volume":"29","author":"J McColm","year":"2014","unstructured":"McColm J, Hu L, Womack T, Tang CC, Chiang AY (2014) Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women. J Bone Miner Res 29:935\u2013943","journal-title":"J Bone Miner Res"},{"key":"79_CR124","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1359\/jbmr.2000.15.5.936","volume":"15","author":"S Kasugai","year":"2000","unstructured":"Kasugai S, Fujisawa R, Waki Y, Miyamoto K, Ohya K (2000) Selective drug delivery system to bone: small peptide (Asp)6 conjugation. J Bone Miner Res 15:936\u2013943","journal-title":"J Bone Miner Res"},{"key":"79_CR125","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1210\/endo.142.3.8024","volume":"142","author":"K Yokogawa","year":"2001","unstructured":"Yokogawa K, Miya K, Sekido T, Higashi Y, Nomura M, Fujisawa R, Morito K, Masamune Y, Waki Y, Kasugai S, Miyamoto K (2001) Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice. Endocrinology 142:1228\u20131233","journal-title":"Endocrinology"},{"key":"79_CR126","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2006.02.012","volume":"88","author":"T Nishioka","year":"2006","unstructured":"Nishioka T, Tomatsu S, Gutierrez MA, Miyamoto K, Trandafirescu GG, Lopez PL, Grubb JH, Kanai R, Kobayashi H, Yamaguchi S, Gottesman GS, Cahill R, Noguchi A, Sly WS (2006) Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide. Mol Genet Metab 88:244\u2013255","journal-title":"Mol Genet Metab"},{"key":"79_CR127","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1359\/jbmr.071213","volume":"23","author":"JL Millan","year":"2008","unstructured":"Millan JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikova S, Terkeltaub R, Camacho NP, McKee MD, Crine P, Whyte MP (2008) Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23:777\u2013787","journal-title":"J Bone Miner Res"},{"key":"79_CR128","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bone.2011.03.770","volume":"49","author":"MC Yadav","year":"2011","unstructured":"Yadav MC, Lemire I, Leonard P, Boileau G, Blond L, Beliveau M, Cory E, Sah RL, Whyte MP, Crine P, Millan JL (2011) Dose response of bone-targeted enzyme replacement for murine hypophosphatasia. Bone 49:250\u2013256","journal-title":"Bone"},{"key":"79_CR129","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/154405910208101204","volume":"81","author":"FH Nociti Jr","year":"2002","unstructured":"Nociti FH Jr, Berry JE, Foster BL, Gurley KA, Kingsley DM, Takata T, Miyauchi M, Somerman MJ (2002) Cementum: a phosphate-sensitive tissue. J Dent Res 81:817\u2013821","journal-title":"J Dent Res"},{"key":"79_CR130","doi-asserted-by":"publisher","first-page":"e38393","DOI":"10.1371\/journal.pone.0038393","volume":"7","author":"BL Foster","year":"2012","unstructured":"Foster BL, Nagatomo KJ, Nociti FH Jr, Fong H, Dunn D, Tran AB, Wang W, Narisawa S, Millan JL, Somerman MJ (2012) Central role of pyrophosphate in acellular cementum formation. PLoS ONE 7:e38393","journal-title":"PLoS ONE"},{"key":"79_CR131","doi-asserted-by":"publisher","unstructured":"Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson D, Bishop N, Hofmann C, study ENB-002\u201308, ENB-003\u201308, ENB-010\u201310ENB-011\u201310 Investigators (2015) Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab. doi: 10.1210\/jc.2015-3462","DOI":"10.1210\/jc.2015-3462"},{"key":"79_CR132","unstructured":"Whyte MP, Madson KL, Phillips KL, Reeves A, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fugita K, Thompson D, Moseley S, Odrljin T, Greenberg CR Asfotase alfa therapy for children with hypophosphatasia (submitted)"},{"key":"79_CR133","doi-asserted-by":"crossref","unstructured":"Kiffer-Moreira T, Sheen CR, Gasque K, Bolean M, Ciancaglini P, Van Elsas A, Hoylaerts MF, Mill\u00e1n JL (2014) Catalytic signature of a heat-stable, chimeric human alkaline phosphatase with therapeutic potential. PLoS One 9(2):e89374","DOI":"10.1371\/journal.pone.0089374"},{"key":"79_CR134","doi-asserted-by":"crossref","unstructured":"Yamamoto S, Orimo H, Matsumoto T, Iijima O, Narisawa S, Maeda T, Mill\u00e1n JL, Shimada T (2011) Prolonged survival and phenotypic correction of\u00a0Akp2(\u2212\/\u2212)\u00a0hypophosphatasia mice by lentiviral gene therapy. J Bone Miner Res 26:135\u2013142","DOI":"10.1002\/jbmr.201"},{"key":"79_CR135","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1089\/hum.2010.210","volume":"22","author":"T Matsumoto","year":"2011","unstructured":"Matsumoto T, Miyake K, Yamamoto S, Orimo H, Miyake N, Odagaki Y, Adachi K, Iijima O, Narisawa S, Mill\u00e1n JL, Fukunaga Y, Shimada T (2011) Rescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphatase. Hum Gene Ther 22:1355\u20131364","journal-title":"Hum Gene Ther"},{"key":"79_CR136","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/hum.2011.148","volume":"23","author":"H Sugano","year":"2012","unstructured":"Sugano H, Matsumoto T, Miyake K, Watanabe A, Iijima O, Migita M, Narisawa S, Millan JL, Fukunaga Y, Shimada T (2012) Successful gene therapy in utero for lethal murine hypophosphatasia. Hum Gene Ther 23:399\u2013406","journal-title":"Hum Gene Ther"},{"key":"79_CR137","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jbmr.2420","volume":"30","author":"CR Sheen","year":"2015","unstructured":"Sheen CR, Kuss P, Narisawa S, Yadav MC, Nigro J, Wang W, Chlea TN, Sergienko E, Kapoor K, Jackson MR, Hoylaerts MF, Pinkerton AB, O\u2019Neill WC, Mill\u00e1n JL (2015) Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification. J Bone Miner Res 30:824\u2013836. doi: 10.1002\/jbmr.2420","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-015-0079-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0079-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-015-0079-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:07:09Z","timestamp":1718208429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-015-0079-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,21]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["79"],"URL":"https:\/\/doi.org\/10.1007\/s00223-015-0079-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,21]]},"assertion":[{"value":"16 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"JLM and MPW have received grant support, honoraria, and travel reimbursements from Alexion Pharmaceuticals, Cheshire, CT. JLM has received grant support and honoraria from AM-Pharma, Bunnik, The Netherlands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}